We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Evolve Capital | LSE:EVOL | London | Ordinary Share | GB00B29WXB29 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.375 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMEVOL
RNS Number : 0832V
Evolve Capital PLC
08 January 2013
8 January 2013
Evolve Capital plc
("Evolve" or the "Company")
Result of General Meeting
and
adjournment of the meeting prior to consideration of the Delisting
Introduction
On 19 December 2012 the Company announced proposals, subject to approval of its shareholders at a general meeting to be held today (the "General Meeting"), to:
(i) approve the transfer by St Helens Capital Partners LLP, the Company's wholly owned ISDX advisory business ("St Helens"), of its business to Peterhouse Corporate Finance Limited ("Peterhouse") (the "Disposal"); and
(ii) cancel the admission of the ordinary shares of 0.1p each in the capital of the Company (the "Ordinary Shares") to trading on AIM, a market operated by the London Stock Exchange plc ("AIM") (the "Delisting").
The Company sent a circular to its shareholders (the "Circular") setting out further details of the Disposal and the Delisting and the implications for shareholders of the Company. The Circular contained a recommendation from the board of Evolve for shareholders to vote in favour of the Disposal and the Delisting.
Yesterday the Company announced that it had received a request from a number of shareholders in Evolve who had asked for the opportunity to meet with the board of Evolve to discuss the proposed arrangements for the provision of information to shareholders, share trading, corporate governance and shareholder protections in general, that would be put in place following the Delisting prior to giving consideration to the special resolution being proposed at the General Meeting to approve the Delisting.
The Company also announced that it was sympathetic to the request and that in order to facilitate discussions it had agreed to adjourn the General Meeting, following the consideration of Resolution 1, the ordinary resolution to approve the Disposal, for a period of 21 days.
Result of General Meeting
The Board is pleased to announce that at today's General Meeting the resolution in respect of the Disposal was duly passed. As a consequence the transfer of the St Helens' business to Peterhouse has completed.
Adjourned General Meeting to consider Delisting and revised timetable for Delisting
The adjourned meeting to consider the Delisting will be held on 29 January 2013 at 11.00 am at the offices of Marriott Harrison, Staple Court, 11 Staple Inn Buildings, London WC1V 7QH (the "Adjourned General Meeting"). Proxy votes that have been cast on the Delisting Resolution will remain valid for the Adjourned General Meeting. The deadline for submitting proxies or for changing proxies that have already been submitted in relation to Resolution 2 will be 24 hours before the date of the Adjourned General Meeting.
Should the Delisting be approved by Shareholders at the Adjourned General Meeting it is anticipated that the trading in the Ordinary Shares on AIM will cease at close of business on 5 February 2013 with the Delisting taking effect at 7:00 a.m. on 6 February 2013.
Should the Delisting not be approved by Shareholders at the Adjourned General Meeting, the Company will continue to be listed on AIM and, as a consequence of the costs associated with remaining on the market, the funds that will be available for eventual distribution to shareholders will be diminished. It will also be necessary for the Company to convene another general meeting at which to obtain shareholders' consent for a new investing policy and the costs involved in this exercise will further diminish the funds that will be available for eventual distribution to shareholders.
Further announcements will be made as appropriate.
For further enquiries please contact
Evolve Capital plc:
Oliver Vaughan 020 7937 4445
Allenby Capital Limited (Nominated adviser and broker):
Nick Naylor or Nick Athanas 020 3328 5656
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCSSMFDAFDSEIF
1 Year Evolve Capital Chart |
1 Month Evolve Capital Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions